The Association of British HealthTech Industries (ABHI) has revealed some of the digital health technologies, services and products being launched at the ABHI UK Pavilion at Arab Health 2020.
The show presents opportunities for UK companies to connect with buyers and clinicians in the Middle East.
Each year, the ABHI UK Pavilion provides platform for UK companies wishing to introduce their innovations to the Middle Eastern healthcare market.
The 2020 exhibition sees a range of exciting new products and services, including a portable neonatal CPAP device specifically designed for low resource settings. Recently shortlisted for an Innovation in Anaesthesia, Critical Care and Pain Award, UK manufacturer Diamedica’s latest innovation provides a small, hands-free respiratory solution for preterm babies, neonates and paediatrics. The device is designed for use in challenging locations, including the delivery room, or during transport or power outage.
Joining them on the ABHI stand is British manufacturer Medezine, who will be showcasing its new range of portable, lightweight medical saws at the show. The new Medezine range of Cast Removal Saws and Mortuary Autopsy Saws aims to provide patient and user safety, and a solution tailored to global clinical needs.
Another technology being launched on the ABHI pavilion comes from Cambridge-based manufacturer Cambrionix. Designed to take the pain out of mobile device management, its new modular charging station ModIT provides a new approach for charging, storing and syncing multiple mobile devices at the same time – offering a solution for healthcare settings, aimed to deliver benefits for physicians and medical staff, as well as practice managers and hospital IT departments.
Vital Innovations will be showcasing its UV steriliser & dryer – designed to dry-disinfect any item without using chemicals, heat, steam or sterilising solution. The vital baby Nurture pro UV steriliser & dryer uses ultraviolet LED technology to kill 99.9% of bacteria (commonly found on items, including on bottles and accessories, teethers, toys, and cosmetic products). It can be used in both home and clinical settings, including for parents, paediatric wards and maternity units.
GenesisCare will be launching Theranostics to enable access to patients in the Middle East. The objective is to slow tumour growth, reduce symptoms and improve quality of life. Theranostics combines two treatments in one: diagnostic imaging and therapy. The diagnostic approach uses a radioactive tracer (Gallium-68 PSMA) bound to molecules that are specific to receptors found on the surface of cancer cells, enabling detection of metastases using PET/CT. Lutetium-177 PSMA therapy is equally specific and delivers targeted radiation to the same protein receptor. Due to its minimal toxicity most patients can receive multiple cycles of treatment.
SunVit-D3 will be launching its unique Calcium chewable tablets to consumers in the region. The product, using a combination of Calcium and Vitamin D3, is primed to meet the demands of consumers in the MENA region, where limited sun exposure due to cultural practices, dark skin colour, very hot climates and decreased calcium content in local diets can have a detrimental impact on bone health. Available in three fruity flavours, the calcium tablets are designed to help with the maintenance of normal bones, teeth and muscle function.
Paul Benton, managing director, International, ABHI said: “The UK is leading the way in healthcare innovation, and we are proud to be able to provide an international platform for British companies looking to expand their services to the Middle East. It’s an exciting time for patient-centred and technology-enabled transformation of care.”
Arab Health takes place 27 January – 30 January 2020 at the Dubai World Trade Centre.
